(1 - 8 von 16
)
Probe of sales practices may hurt stent market | Star Tribunewww.startribune.com › probe-of-sales-practices-may...
www.startribune.com
· ... J&J in June estimated a $1.8 billion market for the stents by 2012, which now seems unlikely, said Frost & Sullivan Inc. analyst Venkat Rajan.
Medtech Companies Face Job Cuts | CHEManager
www.chemanager-online.com
"It's easy to blame the tax, but it's something that would have happened eventually at these companies," said Frost & Sullivan analyst Venkat Rajan. The industry's sales were growing at close to double-digit rates for about a decade from the mid-1990s, bolstered by advances in minimally invasive technology and different types of safer and ...
sortiert nach Relevanz / Datum